CASC3 and Miyoshi myopathy: To evaluate whether TLR4 inhibition resensitizes primary cells to BTZ-induced apoptosis, CD138+ cells derived from five refractory MM patients were treated for 48h with 5 nM BTZ, 10–20 μM TAK-242 or their combination.